Seite 1 – Lebenslauf von Fischer Gabriele E UROPASS C URRICULUM V ITAE PERSONAL INFORMATION name Univ. Prof. Dr. Gabriele Fischer address privat Kochgasse 3-5/12a, 1080 Wien, Austria address work Medical University of Vienna Center for Public Health Department of Psychiatry & Psychotherapy Währinger Gürtel 18-20, 1090 Vienna, Austria phone 0043 1 40400 21170 fax 0043 1 40400 36290 e-mail [email protected]home page www.sucht-news.at nationality Austria date of birth 27.01.1960 WORK EXPERIENCE since 2013 European Monitoring Center for Drugs and Drug Addiction (EMCDDA) Member of scientific board since 2011 Center for Public Health Medical University Vienna Kinderspitalgasse 15, 1090 Vienna Project Leader „Addiction in Public Health“ since 01.10.2000 Department of Psychiatry & Psychotherapy, Medical University of Vienna Spitalgasse 23, 1080 Vienna Professor for Psychiatry – Addiction Research and Treatment Medical Director of Addiction Clinic since 2000 Austrian Federal Ministry of Health Austrian Medical Advisory Council Member since 2000 UNODOC and WHO Consultant from 1992 – to 2000 Department of Psychiatry & Psychotherapy, Medical University of Vienna Head of Units from 01.03.1992 to 28.02-1995 Department of Psychiatry & Psychotherapy, Medical University of Vienna Co-director: Intensive care Unit (emergency) from 01.01.1993 to 01.10.1994 Department of Psychiatry & Psychotherapy, Medical University of Vienna
7
Embed
PERSONAL INFORMATION - Medizinischen …Seite 1 – Lebenslauf von Fischer Gabriele EUROPASS CURRICULUM VITAE PERSONAL INFORMATION name Univ. Prof. Dr. Gabriele Fischer address privat
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
Seite 1 – Lebenslauf von Fischer Gabriele
E U R O P A S S C U R R I C U L U M V I T A E
PERSONAL INFORMATION
name Univ. Prof. Dr. Gabriele Fischer
address privat Kochgasse 3-5/12a, 1080 Wien, Austria
since 2013 European Monitoring Center for Drugs and Drug Addiction (EMCDDA) Member of scientific board
since 2011 Center for Public Health Medical University Vienna
Kinderspitalgasse 15, 1090 Vienna Project Leader „Addiction in Public Health“
since 01.10.2000 Department of Psychiatry & Psychotherapy, Medical University of Vienna Spitalgasse 23, 1080 Vienna
Professor for Psychiatry – Addiction Research and Treatment Medical Director of Addiction Clinic
since 2000 Austrian Federal Ministry of Health
Austrian Medical Advisory Council Member
since 2000 UNODOC and WHO Consultant
from 1992 – to 2000 Department of Psychiatry & Psychotherapy, Medical University of Vienna
Head of Units
from 01.03.1992 to 28.02-1995
Department of Psychiatry & Psychotherapy, Medical University of Vienna Co-director: Intensive care Unit (emergency)
from 01.01.1993 to 01.10.1994 Department of Psychiatry & Psychotherapy, Medical University of Vienna
Seite 2 – Lebenslauf von Fischer Gabriele
Director: Forensic Addiction Clinic
from 31.12.1991 to 01.01.1992 Department of Psychiatry & Psychotherapy, Medical University of Vienna Co-Director: Behavioural Therapy Unit
since 1991 Licenced Specialist as Psychiatrist & Neurologist
from 1986 to 1990 Department of Psychiatry & Psychotherapy, Medical University of Vienna Residency in Psychiatry
from 01.05.1989-30.10.1989 Department of Neurology, Medical University of Vienna Residency in Neurology
from 1987 to 1989 Washington University, Department of Psychiatry, St. Louis, USA
Visiting fellow, research education in epidemiology, basic neuroscience & statistics with a focus in addiction psychiatry & personality disorders
from 01.01.1985 to 31.03.1986 II. Internal Medical University Clinic, Vienna
Residency in Internal Medicine
from 01.05.1984 to 31.12.1984 Department of Child and Adolescent Psychiatry, Medical University of Vienna Residency in Adolescent Psychiatry
EDUCATION AND TRAINING
23.05.2000 Department of Psychiatry & Psychotherapy, Medical University of Vienna
Habilitation Subject: Addiction research and therapy
10.10.1998 University of Vienna Graduation in hospital management and administration
from 1996 to 1998 University of Vienna Post gradual education in hospital management and administration
since 29.01.1995 Licenced medical specialist for Intensive Care
from 1986 to 1992 Psychotherapeutic education in Behavioural Therapy
since 1991 Licenced specialist as Psychiatrist & Neurologist
from 1989 to 1990 Department of Psychiatry & Psychotherapy, Medical University of Vienna Residency in Psychiatry
from 1987 to 1989 Washington University, Department of Psychiatry/Jewish hospital Medical School of St. Louis USA Visiting fellow; Research education in epidemiology basic neuroscience & statistics with focus in
addiction psychiatry & gender/sex aspects
from 1984to 1986 Department of Psychiatry & Psychotherapy, Medical University of Vienna Residency in Psychiatry
16.04.1984 University of Vienna Promotion Dr. med. Univ. Medical Degree
from 1978 to 1984 University of Vienna, Medical Department
Student
1978 High school Wels General qualification for university access
from 1974 to 1978 High school Wels
Student
Seite 3 – Lebenslauf von Fischer Gabriele
from 1970 to 1974 High school Stainach
Student
from 1966 to 1970 Elementary school Student
PERSONAL SKILLS
MOTHER TONGUE GERMAN
OTHER LANGUAGES
ENGLISH • understanding excellent
• reading excellent • speaking excellent
French
• understanding Good • reading adequate
• speaking adequate
ORGANISATIONAL & MANAGERIAL
SKILLS
since 2011 MINI MED Studies
Board member
since 1995 Organisation of training courses, meetings, workshops and conferences
from 16.07.2013 to 16.10.2013 Austrian Federal Ministry of Justice Task force of minister: imprisonment on remand for youth: prevention-reduction-execution
from 2008 to 2013 Medical University of Innsbruck Chair of University Board of Trustees www.i-med.ac.at
from 2003 to 2013 Medical University of Innsbruck Member of University Board of Trustees www.i-med.ac.at
from 2007 to 2010 Austrian Society for Gender Medicine Board member
from 1994 to 2003 University of Vienna, Medical faculty Member of the committee for gender equality
COMMUNICATION SKILLS
since 1990 Medical University of Vienna
Lecturer (Betrauungsdekret) Diagnostic und Therapy of addictive disorders Psychiatric and behavioural disorders related to psychotropic substances under consideration of
gender aspects Gender lectures MCW 20
since 1985 Lectures and presentations at national and international conferences
Seite 4 – Lebenslauf von Fischer Gabriele
since 1985
COMPUTER SKILLS
Scientific publications in national and international peer reviewed journals, book contributions and books
Word Power Point Excel SPSS
DRIVING LICENCE
Category A und B
ADDITIONAL INFORMATIONS
AWARDS
2008
Chimera Award, Sofia, Bulgaria
2007 Chimera Award, Pietrassanta, Italy
2000 CNS Research Award, Austrian Society for Neurology and Psychiatry, Supreme Award (founded
by Pfizer)
1998 University Vienna Award, Women’s Forum
MEMBERSHIP
Scientific Associations CPDD College on Problems of Drug Dependence ECNP European College of Neuropsychopharmacology European Methadone Association EPA-gender section: gender differences and substance use disorder IDHDP International Doctors of Healthy Drug Policies ISAM International Society of Addiction Medicine NEAR Network of Excellence in Addiction Research ÖGPP Austrian Society for Psychiatry & Psychotherapy Society for the Study of Addiction and Alcohol and Other Drugs
Scientific or Advisory Board Member of Austrian Medical Council
Scientific advisory board: Addiction und ADHD EUFAS European Federation of Addiction Societies Eureka Eurostars: Advisory board member for EU framework grants UNODOC
Technical consultant; treatment implementation for substance dependent women & children in Afghanistan
WHO Currently: Development on guidelines for diagnoses and treatment of substance dependence in pregnancy
WPA Section on Dual Disorders/Pathology
Editorial board Archives of Women´s Mental Health European Addiction Research European Neuropsychopharmacology Frontiers
Seite 5 – Lebenslauf von Fischer Gabriele
Heroin Addiction and Related Clinical Problems PLOS ONE Psychology of Addictive Behaviors Research Journal of Drug Abuse Suchtmedizin Suchttherapie Wiener Klinische Wochenschrift
Senior Editor Addiction
Associate Editor Frontiers in Pharmacology
Assistant Editor Addiction Cochrane European Addiction Research Frontiers in Clinical Trials and Pharmacotherapy
Reviewer Addiction Archives of General Psychiatry
British Medical Journal Drug and Alcohol Review Drug and Alcohol Dependence European Addiction Research European Journal of Clinical Investigation European Neuropsychopharmacology European Psychiatry International Journal of Psychiatry in Clinical Practice Journal of Psychopharmacology Pharmacopsychiatry Psychiatrie und Psychotherapie SPPE Social Psychiatry and Psychiatric Epidemiology Suchtmedizin in Forschung und Praxis Suchttherapie Wiener Klinische Wochenschrift Wiener Medizinische Wochenschrift And others
PROJECTS
EU Grants
2011 - 2014 REDUCE Project: Reducing hepatitis C sexual and drug taking risk behaviours among female
drug users in Europe: translating evidence into practice. European Commission, Directorate – General Justice. EU Contract Nr.: JLS/2009-2010/DPIP/AG/4000000975
2010 - 2011 Study on the Development of a EU Framework for minimum quality standards and benchmarks
in drug demand reduction. European Commission Directorate General Justice, Liberty and Security EU contract Nr.: JLS 2010/DPIR/PR/1023
2005 - 2010 EU Model of good practice in drug treatment in Europe – More Treat 6th framework program
EU contract Nr.: F32117831
2002 - 2004 Rose – Management of high risk opiate addicts 5th framework program EU contract Nr.: QLG4-CT-2002-01681
2002 - 2004 Cocaine – cocaine 5th framework program
EU Grant Nr.: QLGA-CT-2001-02301
Seite 6 – Lebenslauf von Fischer Gabriele
NIH Grants
2010 - 2013 Supplement: Developmental investigation on neonates exposed to buprenorphine vs. methadone NIH Grant Nr.: 1R01DA018417-01
double-blind study to compare Methadone and Buprenorphine for treatment of opioid dependent women during their pregnancy and consequences on Neonatal Abstinence Syndrome (NAS) NIH Grant Nr.: 1R01 DA18417-01
Open Society Institute
August – November 2013 Substance abuse during pregnancy: prevention, detection and treatment. Network initiative
Funds by
Austrian National Bank
2009 - 2013 Pregnancy: Substance-related consequences for fetus and neonates
Anniversary Fund ÖNB Nr.: 13637
2006 – 2008 Quality of experience survey of opioid addicted patients in opioid maintenance therapy: Quality of life and mortality rate. ÖNB Nr.: 11650
2002 – 2005 Addiction and pregnancy: Evaluation of health related factors in neonates and their mothers
1996 - 1997 Buprenorphine/Methadone in opioid maintenance therapy
ÖNB Nr.: 5818
Mayor Funds
1997 - 1999 Buprenorphine opioid maintenance therapy in opioid addicted women Mayor Fund Nr.: 1475
1997 - 1998 Influence of methadone, morphine, buprenorphine and naltrexone on humoral and cellular
immune parameters in opioid addicted patients undergoing opioid maintenance therapy in comparison to heroin addicts Mayor Fund Nr.: 1450
1996 - 1997 Morphine maintenance in opioid dependent pregnant women
Mayor Fund Nr. 1334
Other third party funding projects
since 2013 Prevalence of adult attention deficit/hyperactivity disorder and comorbid psychiatric disorders in patients with substance use disorder or problematic gambling as well as non treatment-seeking gamblers.
since 2011 Development of a morphine-naloxone combination tablet: Phase II single centre double blinded
cross over dose confirmation study using two morphine-naloxone intravenous solutions
since 2011 Lifestyle survey with particular focus on eating behaviour in students
2008 Prevalence of substance use disorder in pathological gambling
2008 - 2010 A randomized open – label, multicenter, efficacy and safety study examining the effects of 24
Seite 7 – Lebenslauf von Fischer Gabriele
versus 48 weeks of combination therapy with Pegasys Peginterferon Alfa-2a 40 KD plus Copegus (Ribavarin) on Sustained virological response in patients with chronic Hepatitis C, Genotyp 2 or 3 who do not achieve a rapid viral response. (RO 25-8310 und RO 20-99-63)
2007 - 2008 Evaluation of switching opioid dependent patients to SuboxoneR. Acceptance, safety and
consequences for medication (PO 5444)
2008 Vienna research festival – „Addiction-parcours“
2006 - 2008 Prevalence of addictive disorders with focus on non-substance related dependence: sex/gender aspects and comorbidity.
2005 - 2008 Hepatitis C Genotyp 2/3 study ML17087; Randomised, multicentre study to compare efficiency
of pegylised interferon ALFA 2A (Peg-INF 2A) in combination with two different doses of Ribavirin in patients with chronic Hepatitis C Subtyp 2/3.
2005 - 2008 Quality assurance in the implementation of slow release oral morphine for
treatment of opioid dependence and involvement of general practitioners.
2004 - 2008 Webportal – substance use disorder – international comparison
2001 - 2003 Application of morphine with particular focus on interdisciplinary cooperation with general practitioners.
1996 - 2003 Educational Grants for production of various brochures and guidelines
2001 - 2002 Controlled application of buprenorphine with particular focus on gender aspects (Cooperation
with general practitioners)
2001 Controlled application of buprenorphine with particular focus on incorporation of general practitioners.
2000 Application of slow release oral morphine with particular focus on introduction.
2000 Application of slow release oral morphine in opioid addicted patients.
1999 - 2000 Comparison of efficiency and tolerance of morphinsulfate – Retardgranulat versus Methadone